Nevro Corp. (NVRO)

Market Cap	418.39M
Revenue (ttm)	425.17M
Net Income (ttm)	-92.21M
Shares Out	36.40M
EPS (ttm)	-2.56
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,069
Open	11.55
Previous Close	11.62
Day's Range	11.48 - 11.75
52-Week Range	11.48 - 30.27
Beta	0.89
Analysts	Hold
Price Target	19.58 (+70.19%)
Earnings Date	May 7, 2024

About NVRO

Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implant...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Nov 6, 2014
• Employees: 1,215
• Stock Exchange: NYSE
• Ticker Symbol: NVRO

Analyst Forecast

According to 13 analysts, the average rating for NVRO stock is "Hold." The 12-month stock price forecast is $19.58, which is an increase of 70.19% from the latest price.

Price Target

$19.58

(70.19% upside)

Analyst Consensus: Hold